Nobleoak LifeASX:NOL 54 3-Year RORE % is -12.50 as of Dec. 2025. GuruFocus rates ASX:NOL with a GF Score™ of 54/100 and a GF Value™ of A$1.76 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 474 Insurance companies, Nobleoak Life ranks worse than 74.89% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Nobleoak Life's 3-Year RORE % for the quarter that ended in Dec. 2025 was -12.50%.
The industry rank for Nobleoak Life's 3-Year RORE % or its related term are showing as below:
ASX:NOL's 3-Year RORE % is ranked worse than 74.89% of 474
companies
in the Insurance industry
Industry Median: 11.865
vs ASX:NOL: -12.50
Nobleoak Life (ASX:NOL) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Nobleoak Life 3-Year RORE % Related Terms
Nobleoak Life 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Nobleoak Life's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:NOL vs AFL, MET, PRU: 3-Year RORE % Comparison
For the Insurance - Life subindustry, Nobleoak Life's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nobleoak Life 3-Year RORE % vs Insurance Industry
For the Insurance industry and Financial Services sector, Nobleoak Life's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Nobleoak Life's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
Nobleoak Life (ASX:NOL) has a 3-Year RORE % of -12.50 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Nobleoak Life and its competitors. According to the industry distribution chart, Nobleoak Life ranks #355 out of 474 companies in the Insurance industry, placing it in the top 74.9%.
Is Nobleoak Life's 3-Year RORE % too high?
Nobleoak Life's current 3-Year RORE % is -12.50. Based on the distribution chart, Nobleoak Life ranks #355 out of 474 companies in the Insurance industry, which is below the industry midpoint. Overall, Nobleoak Life has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nobleoak Life's 3-Year RORE % compare to AFL and MET?
According to the Insurance industry distribution chart, Nobleoak Life ranks #355 out of 474 companies for 3-Year RORE %. This places Nobleoak Life in the lower half of its industry. The industry median 3-Year RORE % is 11.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for an Insurance company?
The median 3-Year RORE % among Insurance companies is 11.87, based on 474 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Nobleoak Life and its competitors. For the Insurance industry, the median 3-Year RORE % is 11.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nobleoak Life's current 3-Year RORE % is -12.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nobleoak Life stock overvalued right now?
Based on GuruFocus' analysis, Nobleoak Life (ASX:NOL) is currently considered Modestly Undervalued. The stock's GF Value™ is A$1.76, compared to a current price of A$1.25 — trading 29.3% below its estimated fair value. The current 3-Year RORE % is -12.50. Nobleoak Life's overall GF Score™ is 54/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Nobleoak Life (ASX:NOL), the current 3-Year RORE % is -12.50 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nobleoak Life (ASX:NOL) Overvalued in 2026?
Based on GuruFocus' analysis, Nobleoak Life stock appears to be undervalued.
The current stock price of A$1.25 is trading 29.3% below its estimated GF Value™ of A$1.76.
GuruFocus considers Nobleoak Life to be Modestly Undervalued.
Key valuation signals for ASX:NOL:
3-Year RORE %: -12.50
GF Value™: A$1.76 vs. price of A$1.25 (29.3% below fair value)
No single metric tells the full story. See the ASX:NOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and Strategic Partner (Advised) channels. The company's segments include Direct Business, Strategic Partnerships, and Genus. It generates maximum revenue from the Direct segment.
54GF Score
Get the complete analysis for ASX:NOL
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:NOL has been successfully added to your 
